HKD 9.13
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 252.66 Million CNY | 21.31% |
2022 | 174.96 Million CNY | 2.04% |
2021 | 211.31 Million CNY | -7.81% |
2020 | 189.38 Million CNY | 53.67% |
2019 | 155.78 Million CNY | -17.27% |
2018 | 160.11 Million CNY | 48.32% |
2017 | 104.56 Million CNY | -2.02% |
2016 | 115 Million CNY | 29.86% |
2015 | 95.4 Million CNY | 14.72% |
2014 | 83.16 Million CNY | 31.22% |
2013 | 63.46 Million CNY | 76.45% |
2012 | 35.96 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q3 | 46.75 Million CNY | -16.86% |
2023 FY | - CNY | 21.31% |
2023 Q4 | 46.75 Million CNY | 0.0% |
2023 Q1 | 56.24 Million CNY | 209.67% |
2023 Q2 | 56.24 Million CNY | 0.0% |
2022 Q1 | 61.39 Million CNY | 61.3% |
2022 FY | - CNY | 2.04% |
2022 Q4 | 18.16 Million CNY | 0.0% |
2022 Q3 | 18.16 Million CNY | -70.42% |
2022 Q2 | 61.39 Million CNY | -0.0% |
2021 Q1 | 46.18 Million CNY | 18.96% |
2021 Q2 | 46.18 Million CNY | 0.0% |
2021 FY | - CNY | -7.81% |
2021 Q4 | 38.06 Million CNY | 0.0% |
2021 Q3 | 38.06 Million CNY | -17.59% |
2020 Q4 | 38.82 Million CNY | -0.0% |
2020 Q2 | 41.52 Million CNY | -0.0% |
2020 FY | - CNY | 53.67% |
2020 Q1 | 41.52 Million CNY | 92.81% |
2020 Q3 | 38.82 Million CNY | -6.5% |
2019 Q4 | 21.53 Million CNY | 0.0% |
2019 Q3 | 21.53 Million CNY | -21.09% |
2019 Q2 | 27.29 Million CNY | -0.0% |
2019 Q1 | 27.29 Million CNY | -28.59% |
2019 FY | - CNY | -17.27% |
2018 Q4 | 38.21 Million CNY | 0.0% |
2018 Q3 | 38.21 Million CNY | -15.12% |
2018 Q2 | 45.02 Million CNY | -0.0% |
2018 Q1 | 45.02 Million CNY | 20.25% |
2018 FY | - CNY | 48.32% |
2017 FY | - CNY | -2.02% |
2017 Q4 | 37.44 Million CNY | 0.0% |
2017 Q3 | 37.44 Million CNY | 27.09% |
2017 Q2 | 29.46 Million CNY | -0.0% |
2017 Q1 | 29.46 Million CNY | 36.69% |
2016 Q4 | 21.55 Million CNY | 0.0% |
2016 FY | - CNY | 29.86% |
2016 Q3 | 21.55 Million CNY | 9.74% |
2016 Q2 | 19.64 Million CNY | -0.0% |
2016 Q1 | 19.64 Million CNY | -9.28% |
2015 Q1 | 23.23 Million CNY | 7.43% |
2015 FY | - CNY | 14.72% |
2015 Q2 | 23.23 Million CNY | 0.0% |
2015 Q3 | 21.65 Million CNY | -6.82% |
2015 Q4 | 21.65 Million CNY | 0.0% |
2014 Q4 | 21.62 Million CNY | 0.0% |
2014 Q2 | 19.45 Million CNY | 0.0% |
2014 FY | - CNY | 31.22% |
2014 Q1 | 19.45 Million CNY | -6.43% |
2014 Q3 | 21.62 Million CNY | 11.17% |
2013 FY | - CNY | 76.45% |
2013 Q4 | 20.79 Million CNY | 0.0% |
2012 FY | - CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aidigong Maternal & Child Health Limited | 68.84 Million HKD | -266.994% |
UMP Healthcare Holdings Limited | 161.98 Million HKD | -55.985% |
Human Health Holdings Limited | 104.06 Million HKD | -142.801% |
EuroEyes International Eye Clinic Limited | 292.1 Million HKD | 13.501% |
Kato (Hong Kong) Holdings Limited | 133.61 Million HKD | -89.107% |
Bamboos Health Care Holdings Limited | 52.75 Million HKD | -378.919% |
Beijing Health (Holdings) Limited | -44.19 Million HKD | 671.764% |
C-MER Eye Care Holdings Limited | 359.88 Million HKD | 29.791% |
Town Health International Medical Group Limited | 53.5 Million HKD | -372.268% |
Medicskin Holdings Limited | 6.77 Million HKD | -3628.867% |
Hang Chi Holdings Limited | 81.58 Million HKD | -209.692% |